Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bossuyt

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Cytogenetics and Cell Genetics|January 1, 1991
Assignment of the fucosidase pseudogene FUCA1P to chromosome region 2q31----q32P Coucke, K Mangelschots, F Speleman, et al.
Genomics|February 28, 1998
Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene familyW Van Hul, W Wuyts, J Hendrickx, et al.
Acta Gastro-Enterologica Belgica|October 1, 2019
Ulcerative colitis treatment : an insight into daily clinical practiceP Bossuyt, F Baert, J L Coenegrachts, et al.
Human Molecular Genetics|May 1, 1993
X-linked liver glycogenosis: localization and isolation of a candidate geneJ Hendrickx, P Coucke, P Bossuyt, et al.
Journal of the American College of Cardiology|November 1, 1995
Analysis of risk factors for excess mortality after aortic valve replacementH A Verheul, R B van den Brink, B J Bouma, et al.
Journal of Clinical Anesthesia|April 30, 2003
Ambulatory electrical external cardioversion with propofol or etomidateLuc L Herregods, Gudrun P Bossuyt, Luc E De Baerdemaeker, et al.
Acta Gastro-Enterologica Belgica|April 2, 2020
Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)C Reenaers, A Cremer, O Dewit, et al.
European Journal of Human Genetics : EJHG|February 5, 1998
Identification and characterization of a novel member of the EXT gene family, EXTL2W Wuyts, W Van Hul, J Hendrickx, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)D Franchimont, M Ferrante, E Louis, et al.
Digestive Diseases and Sciences|March 19, 2024
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysisL Peyrin-Biroulet, P Bossuyt, D Bettenworth, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cytogenetics and Cell Genetics|January 1, 1991
Assignment of the fucosidase pseudogene FUCA1P to chromosome region 2q31----q32P Coucke, K Mangelschots, F Speleman, et al.
Genomics|February 28, 1998
Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene familyW Van Hul, W Wuyts, J Hendrickx, et al.
Acta Gastro-Enterologica Belgica|October 1, 2019
Ulcerative colitis treatment : an insight into daily clinical practiceP Bossuyt, F Baert, J L Coenegrachts, et al.
Human Molecular Genetics|May 1, 1993
X-linked liver glycogenosis: localization and isolation of a candidate geneJ Hendrickx, P Coucke, P Bossuyt, et al.
Journal of the American College of Cardiology|November 1, 1995
Analysis of risk factors for excess mortality after aortic valve replacementH A Verheul, R B van den Brink, B J Bouma, et al.
Journal of Clinical Anesthesia|April 30, 2003
Ambulatory electrical external cardioversion with propofol or etomidateLuc L Herregods, Gudrun P Bossuyt, Luc E De Baerdemaeker, et al.
Acta Gastro-Enterologica Belgica|April 2, 2020
Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)C Reenaers, A Cremer, O Dewit, et al.
European Journal of Human Genetics : EJHG|February 5, 1998
Identification and characterization of a novel member of the EXT gene family, EXTL2W Wuyts, W Van Hul, J Hendrickx, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)D Franchimont, M Ferrante, E Louis, et al.
Digestive Diseases and Sciences|March 19, 2024
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysisL Peyrin-Biroulet, P Bossuyt, D Bettenworth, et al.
Pageof 5